| Makinson, Alain |
VOGUE, NCT05979311: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy |
|
|
| Recruiting | 3 | 412 | Europe, Japan, RoW | Dolutegravir, Lamivudine, Bictegravir, Emtricitabine, Tenofovir alafenamide | ViiV Healthcare | HIV, HIV Infections | 11/25 | 10/26 | | |
OPTICOV, NCT05587894: OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial |
|
|
| Recruiting | 2 | 256 | Europe | Paxlovid 5 days, Nirmatrevlir/ritonavir, Paxlovid 10 days, Veklury, remdesivir | ANRS, Emerging Infectious Diseases, University Hospital, Geneva | COVID-19, Immunodeficiency | 03/25 | 05/25 | | |
NCT03958786: Frailty in People Living With HIV Aged 70 Years or More |
|
|
| Active, not recruiting | N/A | 512 | Europe | Simplified Geriatric Evaluation, Sampling | ANRS, Emerging Infectious Diseases | HIV Infections | 06/21 | 06/24 | | |
INKASE, NCT05243381: Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection |
|
|
| Recruiting | N/A | 60 | Europe | 20 ml blood test | University Hospital, Montpellier | HIV Infections | 04/23 | 04/24 | | |
NCT04885452: Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort. |
|
|
| Recruiting | N/A | 2000 | Europe | biobank | ANRS, Emerging Infectious Diseases | SARS-CoV Infection, Covid19 | 06/23 | 06/23 | | |
DORASPEP, NCT05761509: "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk" |
|
|
| Completed | N/A | 226 | Europe | Doravirine, Delstrigo®, Pifeltro® | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba, Merck Sharp & Dohme LLC | HIV Infections | 06/24 | 06/24 | | |
| Recruiting | N/A | 6500 | Europe, RoW | | DatAids | HIV Prevention | 01/29 | 01/29 | | |
| Completed | N/A | 282 | Europe | cognitive functional assessment | ANRS, Emerging Infectious Diseases | HIV Infections | 02/24 | 02/24 | | |
| Recruiting | N/A | 30000 | Europe, RoW | | DatAids | HIV | 01/26 | 01/26 | | |
SPLEEN, NCT04199403: Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients |
|
|
| Recruiting | N/A | 6000 | Europe | | Poitiers University Hospital, Pr Pierre BUFFET Institut National de la Transfusion Sanguine, Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier | Asplenia | 01/40 | 01/40 | | |
